Your browser doesn't support javascript.
loading
Cabozantinib-nivolumab sequence in metastatic renal cell carcinoma: The CABIR study.
Vano, Yann-Alexandre; Phan, Letuan; Gravis, Gwenaelle; Korakis, Iphigénie; Schlürmann, Friederike; Maillet, Denis; Bennamoun, Mostefa; Houede, Nadine; Topart, Delphine; Borchiellini, Delphine; Barthelemy, Philippe; Ratta, Raffaele; Ryckewaert, Thomas; Hasbini, Ali; Hans, Sophie; Emambux, Sheik; Cournier, Sandra; Braychenko, Elena; Elaidi, Réza-Thierry; Oudard, Stéphane.
Affiliation
  • Vano YA; Medical Oncology, Hôpital Européen Georges Pompidou, AP-HP Centre-Université Paris Cité, Paris, France.
  • Phan L; INSERM U970, PARCC, Paris, France.
  • Gravis G; Centre de Recherche des Cordeliers, INSERM, Université Paris Cité, Sorbonne Université, Paris, France.
  • Korakis I; ARTIC-Association pour la Recherche de Thérapeutiques Innovantes en Cancérologie, Hôpital Européen Georges Pompidou, AP-HP Centre, Paris, France.
  • Schlürmann F; Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille University, CRCM, Marseille, France.
  • Maillet D; Medical Oncology, Institut Universitaire du Cancer-Toulouse-Oncopole, Toulouse, France.
  • Bennamoun M; Medical Oncology, Centre Hospitalier Intercommunal, Quimper, Quimper, France.
  • Houede N; Medical Oncology, IMMUCARE, Centre Hospitalier Lyon Sud, Institut de Cancérologie des Hospices de Lyon (IC-HCL), Pierre-Bénite, France.
  • Topart D; Medical Oncology, Institut Mutualiste Montsouris, Paris, France.
  • Borchiellini D; Medical Oncology, Institut de cancérologie du Gard, Nimes, Montpellier University, France.
  • Barthelemy P; Medical Oncology, Hopital Saint-Eloi (CHU de Montpellier), Montpellier, France.
  • Ratta R; Medical Oncology, Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France.
  • Ryckewaert T; Medical Oncology, Institut de Cancérologie Strasbourg Europe, Strasbourg, France.
  • Hasbini A; Medical Oncology, Hopital Foch, Suresnes, France.
  • Hans S; Medical Oncology, Centre Oscar Lambret, Lille, France.
  • Emambux S; Medical Oncology, Clinique Pasteur Lanroze, Brest, France.
  • Cournier S; Department of Medical Oncology, Hôpital Henri-Mondor, AP-HP-Université de Paris Est, Créteil, France.
  • Braychenko E; Medical Oncology, Centre Hospitalier Universitaire Poitiers, Poitiers, France.
  • Elaidi RT; ARTIC-Association pour la Recherche de Thérapeutiques Innovantes en Cancérologie, Hôpital Européen Georges Pompidou, AP-HP Centre, Paris, France.
  • Oudard S; ARTIC-Association pour la Recherche de Thérapeutiques Innovantes en Cancérologie, Hôpital Européen Georges Pompidou, AP-HP Centre, Paris, France.
Int J Cancer ; 151(8): 1335-1344, 2022 10 15.
Article in En | MEDLINE | ID: mdl-35603906
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Int J Cancer Year: 2022 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Int J Cancer Year: 2022 Type: Article Affiliation country: France